McLelland believed she had finally found out how to beat her cancer once and for all. And her test results proved her right. Blood tests revealed that her TM2PK tumor markers (a marker of abnormal glycolysis) had dropped from 397 to 21.5—just slightly above a “normal” reading of 15. But McLelland refused to go down without a fight. Taking matters into her own hands, she dug through medical journals, poring over long-forgotten research and overlooked evidence, looking for clues to overcoming her cancer. Jane is winner of the Lifetime Achievement Award 2019 ‘Amazing Women Global’ for unsung heroines. Awarded for Jane’s work educating and helping cancer patients since 2003. NOTE: Some of the drugs and supplements in these protocols can interact resulting in serious side effects. They should only be taken under the supervision of your doctor. However, McLelland cautions that there is no one-size-fits-all approach. Her own experience with her various forms of cancer highlight that fact. Instead, McLelland’s approach focuses on learning which fuel sources your particular cancer uses—and then creating a targeted treatment plan based on that information.

After intensive research, McLelland concluded that all of these drugs would starve the cancer from different angles: dipyridamole cut off cancer’s access to protein, metformin cut off access to glucose, and the statin cut off access to fat. Once the cancer cells were in their weakened state, the addition of etodolac could help finish them off. McLelland underwent surgery to remove the tumor in her lung, and she endured six months of chemo (at a much lower dose than that recommended by her oncologist). But this time, she also employed a strategy to starve the cancer’s stem cells. Just like the cervical cancer, Jane’s lung cancer was initially misdiagnosed (this time as a chest infection). But the benefit of having the improperly read X-ray from four months prior—along with the properly diagnosed X-ray—was the ability to see the rate at which the cancer was growing.McLelland discovered that there were numerous drugs on the market designed for other purposes (like heart disease or infections) that could go beyond diet and supplements to effectively cut off cancer’s various fuel lines. These drugs are considered “off-label,” since they were developed for conditions other than cancer.

I didn’t want to have to relive everything,” said McLelland, “but I knew I had information I had to pass on. It was a social responsibility to provide people with information they weren’t getting elsewhere.” According to doctors and cancer statistics, she should have lived only about 12 weeks after receiving her diagnosis of stage IV cancer.Jane is absolutely brilliant and understands cancer cell biology and off-label drugs better than most oncologists. I know you will learn a lot from this interview. You may even find the breakthrough you’re looking for… Enjoy! I also created a coaching program for cancer patients, caregivers and anyone who is serious about prevention called SQUARE ONE. It contains the step-by-step strategies used by myself and everyone I know who has healed cancer with nutrition and natural, non-toxic therapies.